Retraction
MicroRNA-665 Inhibits the Oncogenicity of Retinoblastoma by Directly Targeting High-Mobility Group Box 1 and Inactivating the Wnt/β-Catenin Pathway
Paper Information
Record ID:
32586
Author(s):
Publication Date:
April 11, 2019
Retraction Date:
September 18, 2021
(4.2 years years ago)
Subjects:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Taylor and Francis - Dove Press
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (21)
21
Total Citations4
Post-Retraction(19.0%)
17
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
3
Within 1 year
0
After 2+ years
621
Days since retraction (latest)
Function of hsa_circ_0006646 as a competing endogenous RNA to promote progression in gastric cancer by regulating the miR-665–HMGB1 axis
Jing Qin, Shuman Zhen, Jiali Wang et al. (10 authors)
Journal of Gastrointestinal Oncology
Open Access
Published: Jun 2023
4 citations
4 citations
621 days after retraction
Exosomes loaded with miR-665 inhibit the progression of osteosarcoma in vivo and in vitro.
Bo Zhang, Yang� Yang, Ran Tao et al. (6 authors)
PubMed
Published: Jan 2022
7 citations
7 citations
105 days after retraction
Long non-coding RNA NHEG1/hsa-miR-665/HMGB1 axis is involved in the regulation of neuroblastoma progression
Yuqing Zhang, Yuping Hu, Aihong Pan et al. (8 authors)
Bioengineered
Open Access
Published: Dec 2021
12 citations
12 citations
83 days after retraction
Downregulation of MIAT reduces the proliferation and migratory and invasive abilities of retinoblastoma cells by sponging miR‑665 and regulating LASP1
Xiabing Xu, Yadong Zhao, Gang Duan et al. (4 authors)
Experimental and Therapeutic Medicine
Open Access
Published: Sep 2021
5 citations
5 citations
4 days after retraction
miR-665 inhibits epithelial-to-mesenchymal transition in bladder cancer via the SMAD3/SNAIL axis
Weiyu Wang, Yufan Ying, Haiyun Xie et al. (13 authors)
Cell Cycle
Open Access
Published: Jul 2021
26 citations
26 citations
79 days before retraction
Damage-Associated Molecular Patterns Modulation by microRNA: Relevance on Immunogenic Cell Death and Cancer Treatment Outcome
María Julia Lamberti, Annunziata Nigro, Vincenzo Casolaro et al. (5 authors)
Cancers
Open Access
Published: May 2021
30 citations
30 citations
117 days before retraction
Investigation of Key Signaling Pathways Associating miR-204 and Common Retinopathies
Ahmad Bereimipour, Leila Satarian, Sara Taleahmad
BioMed Research International
Open Access
Published: Jan 2021
9 citations
9 citations
260 days before retraction
Paper citing miR-665 promotes hepatocellular carcinoma cell mig...
Unknown Authors
Unknown Journal
Published: Dec 2020
261 days before retraction
High mobility group box 1 regulates gastric cancer cell proliferation and migration via RAGE-mTOR/ERK feedback loop
Tuo Tang, Shengnan Wang, Tianyu Cai et al. (8 authors)
Journal of Cancer
Open Access
Published: Dec 2020
17 citations
17 citations
276 days before retraction
Circ_0000527 promotes the progression of retinoblastoma by regulating miR-646/LRP6 axis
Li Zhang, Jie Wu, Yupeng Li et al. (9 authors)
Cancer Cell International
Open Access
Published: Jul 2020
34 citations
34 citations
435 days before retraction
Long noncoding RNA LINC00324 promotes retinoblastoma progression by acting as a competing endogenous RNA for microRNA-769-5p, thereby increasing STAT3 expression
Yi Dong, Guangming Wan, Panshi Yan et al. (6 authors)
Aging
Open Access
Published: May 2020
25 citations
25 citations
501 days before retraction
<p>miR-665 Suppresses the Epithelial–Mesenchymal Transition and Progression of Gastric Cancer by Targeting <em>CRIM1</em></p>
Kun-Zhe Wu, Chun‐Dong Zhang, Cheng Zhang et al. (5 authors)
Cancer Management and Research
Open Access
Published: May 2020
28 citations
28 citations
505 days before retraction
Long noncoding RNA LINC00205 enhances the malignant characteristics of retinoblastoma by acting as a molecular sponge of microRNA-665 and consequently increasing HMGB1 expression
Shu Zhang, Jian Long, Yin Hu
Biochemical and Biophysical Research Communications
Published: Mar 2020
16 citations
16 citations
541 days before retraction
MicroRNA‑936 inhibits the malignant phenotype of retinoblastoma by directly targeting HDAC9 and deactivating the PI3K/AKT pathway
Lishuai Xu, Weidong Li, Qian Shi et al. (7 authors)
Oncology Reports
Open Access
Published: Jan 2020
22 citations
22 citations
618 days before retraction
LncRNA DSCAM-AS1 promotes non-small cell lung cancer progression via regulating miR-577/HMGB1 axis
Zhaohui Qiu, Xixiang Pan, Dongyang You
Neoplasma
Open Access
Published: Jan 2020
19 citations
19 citations
626 days before retraction
HMGB1 Promotes the Proliferation and Metastasis of Lung Cancer by Activating the Wnt/β-Catenin Pathway
Xiao-Hui Wang, Shuying Zhang, Mei Shi et al. (4 authors)
Technology in Cancer Research & Treatment
Open Access
Published: Jan 2020
30 citations
30 citations
626 days before retraction
miR-300 mitigates cancer-induced bone pain through targeting HMGB1 in rat models
Chenglong Liu, Jianping Yang, Haihua Liu et al. (5 authors)
Genes & Genomics
Published: Dec 2019
19 citations
19 citations
635 days before retraction
LncRNA Neat1 mediates miR-124-induced activation of Wnt/β-catenin signaling in spinal cord neural progenitor cells
Yi Cui, Yanyun Yin, Zhifeng Xiao et al. (11 authors)
Stem Cell Research & Therapy
Open Access
Published: Dec 2019
82 citations
82 citations
657 days before retraction
HMGB2 is a negative regulator of telomerase activity in human embryonic stem and progenitor cells
Martin Kučírek, Alireza Jian Bagherpoor, Josef Jaroš et al. (5 authors)
The FASEB Journal
Open Access
Published: Oct 2019
19 citations
19 citations
693 days before retraction
<p>MiR-34c acts as a tumor suppressor in non-small cell lung cancer by inducing endoplasmic reticulum stress through targeting HMGB1</p>
Li Tu, Xiang Long, Weidong Song et al. (9 authors)
OncoTargets and Therapy
Open Access
Published: Jul 2019
26 citations
26 citations
810 days before retraction
High-mobility group protein�B1 silencing promotes susceptibility of retinoblastoma cells to chemotherapeutic drugs through downregulating nuclear factor-κB
Yong Chai, Juhua Xiao, Shouhua Zhang et al. (7 authors)
International Journal of Molecular Medicine
Open Access
Published: Jan 2018
7 citations
7 citations
1347 days before retraction
Quick Stats
Total Citations:
21
Years Since Retraction:
4.2 years
Open Access:
Yes
Last Checked:
Jul 24, 2025